Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott in development agreement with Axis:

This article was originally published in Clinica

Executive Summary

Axis Biochemicals (Norway) is to develop a homocysteine kit for use on Abbott's IMx immunoassay system. The marker is used for cardiovascular risk and nutritional assessment. Standard measurement methods mainly use chromatography and are not generally automated. Abbott will license an antibody clone of homocysteine to Axis and will receive royalty payments. Axis will have the rights to sell any resulting products to existing Abbott customers but Abbott has an option to distribute the assay at a later date.

Topics

UsernamePublicRestriction

Register

MT088260

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel